CKD Bio Corp. Logo

CKD Bio Corp.

Develops APIs, intermediates, and probiotics using fermentation and synthesis.

063160 | KO

Overview

Corporate Details

ISIN(s):
KR7063160006
LEI:
Country:
South Korea
Address:
서울특별시 서대문구 충정로 8, 서울특별시

Description

CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-13 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 6.1 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 3.8 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 847.6 KB
2024-10-25 00:00
영업(잠정)실적(공정공시)
Korean 13.3 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 823.2 KB
2024-07-26 00:00
영업(잠정)실적(공정공시)
Korean 13.3 KB
2024-05-24 00:00
투자판단관련주요경영사항
Korean 13.7 KB
2024-05-16 00:00
분기보고서 (2024.03)
Korean 887.4 KB
2024-04-26 00:00
영업(잠정)실적(공정공시)
Korean 13.3 KB
2024-03-28 00:00
정기주주총회결과
Korean 25.0 KB
2024-03-28 00:00
대표이사(대표집행임원)변경(안내공시)
Korean 5.3 KB
2024-03-20 00:00
감사보고서제출
Korean 12.4 KB
2024-03-20 00:00
사업보고서 (2023.12)
Korean 550.2 KB
2024-03-06 00:00
투자판단관련주요경영사항
Korean 12.0 KB
2024-02-28 00:00
주주총회소집결의
Korean 12.6 KB

Automate Your Workflow. Get a real-time feed of all CKD Bio Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CKD Bio Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CKD Bio Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.